# Theacrine Focus Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/theacrine-focus-randomized-trial-evidence-review
Category: evidence-review
Summary: Theacrine Focus Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are system
Last reviewed: 2026-07-05
Reviewed by: Migaku Evidence Review
# Theacrine Focus Randomized Trial: What the Evidence Says

## Quick Answer

Theacrine Focus Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 research article.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Herbal Interventions in Parkinson’s Disease: A Systematic Review of Preclinical Studies | systematic review | 1 | 2025-05-23 | 10.1007/s10571-025-01556-y |
| Theacrine as a novel ergogenic aid: impact on canoe sprint performance | research article | 4 | 2025-11-30 | 10.1080/15502783.2025.2590097 |

## What The Sources Report

- The hallmark of PD is the degeneration of dopaminergic neurons in the substantia nigra, leading to reduced dopamine levels in the striatum (Bloem et al.). [Zhao Wanlin (2025); evidence level 1]
- However, these therapies fail to address "the root cause" of PD and are associated with long-term side effects, including nausea, headaches, sleep disturbances, and drug-induced motor complications (Li et al.). [Zhao Wanlin (2025); evidence level 1]
- Evidence also indicates that caffeine can exert complementary effects when combined with other stimulants or nutrients, such as carbohydrate gels or gum-based formulations. [Jovanov Pavle (2025); evidence level 4]
- Additionally, caffeine-induced adenosine blockade alters autonomic nervous system activity, resulting in increased systolic blood pressure and heart rate, particularly during physical activity. [Jovanov Pavle (2025); evidence level 4]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For theacrine focus randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhao Wanlin (2025). Herbal Interventions in Parkinson’s Disease: A Systematic Review of Preclinical Studies. DOI: 10.1007/s10571-025-01556-y. PMCID: PMC12102455. PMID: 40410612. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ http://creativecommons.org/licenses/by-nc-nd/4.0/ This article is .... https://pmc.ncbi.nlm.nih.gov/articles/PMC12102455/
- Jovanov Pavle (2025). Theacrine as a novel ergogenic aid: impact on canoe sprint performance. DOI: 10.1080/15502783.2025.2590097. PMCID: PMC12667338. PMID: 41320283. License: https://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access.... https://pmc.ncbi.nlm.nih.gov/articles/PMC12667338/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.